Seeing hope: FDA panel considers gene therapy for blindness

In this Monday, Oct. 2, 2017, photo, sunlight reflected off a window lights up Christian Guardino’s face, as he stands for a portrait outside his home in Patchogue, N.Y. Christian was diagnosed with hereditary blindness and received gene therapy as part of a study. On Thursday, Oct. 12, U.S. Food and Drug Administration advisers will consider whether to recommend approval of the gene therapy. Before treatment, “It was dark, life without light,” Christian said. “I found a way to work through it, to cope with it, and that was music.” (AP Photo/Julie Jacobson)

Click here and log in to view this story

Start Free AccountGet access to 7 premium stories every month for FREE!

Already a Subscriber?Current print subscriber? Activate your complimentary Digital account.

Subscribe NowChoose a package that suits your preferences.

Reports: Google uncovers ads by Russian operatives

Hollywood condemnation of Weinstein grows louder

Share this story

0 Comments

Cancel reply

Your email address will not be published. Required fields are marked *

Name *

Email *

By participating in online discussions you acknowledge that you have agreed to the TERMS OF SERVICE. An insightful discussion of ideas and viewpoints is encouraged, but comments must be civil and in good taste, with no personal attacks. If your comments are inappropriate, you may be banned from posting. To report comments that you believe do not follow our guidelines, send us an email.

For security purposes, check this box before commenting